FDA Inspection 1114642 — OneSource Specialty Pharma Limited

OneSource Specialty Pharma Limited — FEI 3003813519

The FDA completed an inspection of OneSource Specialty Pharma Limited on December 20, 2019 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 20, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures